LIST OF TABLES
TABLE 01. EUROPEAN ANTIBIOTIC MARKET, BY DRUG CLASS , 2019-2027 ($MILLION)
TABLE 02. BETA LACTAM & BETA LACTAMASE INHIBITORS, BY TYPE, 2019-2027 ($MILLION)
TABLE 03. EUROPEAN ANTIBIOTIC MARKET, BY DRUG ORIGIN, 2019-2027 ($MILLION)
TABLE 04. EUROPEAN ANTIBIOTIC MARKET, BY SPECTRUM OF ACTIVITY, 2019-2027 ($MILLION)
TABLE 05. EUROPEAN ANTIBIOTIC MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($MILLION)
TABLE 06. EUROPEAN ANTIBIOTIC MARKET REVENUE, BY COUNTRY, 2019-2027($MILLION)
TABLE 07. GERMANY STERILE GLOVES MARKET, BY DRUG CLASS , 2019-2027
TABLE 08. GERMANY ANTIBIOTIC MARKET, BY DRUG ORIGIN, 2019-2027($MILLION)
TABLE 09. GERMANY ANTIBIOTIC MARKET, BY SPECTRUM OF ACTIVITY, 2019-2027($MILLION)
TABLE 10. GERMANY ANTIBIOTIC MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027($MILLION)
TABLE 11. FRANCE ANTIBIOTIC MARKET, BY DRUG CLASS , 2019-2027
TABLE 12. FRANCE ANTIBIOTIC MARKET, BY DRUG ORIGIN, 2019-2027($MILLION)
TABLE 13. FRANCE ANTIBIOTIC MARKET, BY SPECTRUM OF ACTIVITY, 2019-2027($MILLION)
TABLE 14. FRANCE ANTIBIOTIC MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027($MILLION)
TABLE 15. UK ANTIBIOTIC MARKET, BY DRUG CLASS , 2019-2027
TABLE 16. UK ANTIBIOTIC MARKET, BY DRUG ORIGIN, 2019-2027($MILLION)
TABLE 17. UK ANTIBIOTIC MARKET, BY SPECTRUM OF ACTIVITY, 2019-2027($MILLION)
TABLE 18. UK ANTIBIOTIC MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027($MILLION)
TABLE 19. ITALY ANTIBIOTIC MARKET, BY DRUG CLASS , 2019-2027
TABLE 20. ITALY ANTIBIOTIC MARKET, BY DRUG ORIGIN, 2019-2027($MILLION)
TABLE 21. ITALY ANTIBIOTIC MARKET, BY SPECTRUM OF ACTIVITY, 2019-2027($MILLION)
TABLE 22. ITALY ANTIBIOTIC MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027($MILLION)
TABLE 23. SPAIN ANTIBIOTIC MARKET, BY DRUG CLASS , 2019-2027
TABLE 24. SPAIN ANTIBIOTIC MARKET, BY DRUG ORIGIN, 2019-2027($MILLION)
TABLE 25. SPAIN ANTIBIOTIC MARKET, BY SPECTRUM OF ACTIVITY, 2019-2027($MILLION)
TABLE 26. SPAIN ANTIBIOTIC MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027($MILLION)
TABLE 27. REST OF EUROPE ANTIBIOTIC MARKET, BY DRUG CLASS , 2019-2027
TABLE 28. REST OF EUROPE ANTIBIOTIC MARKET, BY DRUG ORIGIN, 2019-2027($MILLION)
TABLE 29. REST OF EUROPE EUROPEAN ANTIBIOTIC MARKET, BY SPECTRUM OF ACTIVITY, 2019-2027($MILLION)
TABLE 30. REST OF EUROPE ANTIBIOTIC MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027($MILLION)
TABLE 31. EUROPE ANTIBIOTICS MARKET, BY DRUG CLASS , 2017-2025 ($MILLION)
TABLE 32. EUROPE ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2017-2025 ($MILLION)
TABLE 33. EUROPE ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2017-2025 ($MILLION)
TABLE 34. EUROPE ANTIBIOTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 35. ABBOTT: COMPANY SNAPSHOT
TABLE 36. ABBOTT: OPERATING SEGMENTS
TABLE 37. ABBOTT: PRODUCT PORTFOLIO
TABLE 38. ABBVIE: COMPANY SNAPSHOT
TABLE 39. ABBVIE: OPERATING SEGMENT
TABLE 40. ABBVIE: PRODUCT PORTFOLIO
TABLE 41. ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 42. BAYER: COMPANY SNAPSHOT
TABLE 43. BAYER: OPERATING SEGMENTS
TABLE 44. BAYER: PRODUCT PORTFOLIO
TABLE 45. ROCHE: COMPANY SNAPSHOT
TABLE 46. ROCHE: OPERATING SEGMENTS
TABLE 47. ROCHE: PRODUCT PORTFOLIO
TABLE 48. GSK: COMPANY SNAPSHOT
TABLE 49. GSK: OPERATING SEGMENTS
TABLE 50. GSK: PRODUCT PORTFOLIO
TABLE 51. MERCK: COMPANY SNAPSHOT
TABLE 52. MERCK: OPERATING SEGMENTS
TABLE 53. MERCK: PRODUCT PORTFOLIO
TABLE 54. VIATRIS: COMPANY SNAPSHOT
TABLE 55. VIATRIS: OPERATING SEGMENTS
TABLE 56. VIATRIS: PRODUCT PORTFOLIO
TABLE 57. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 58. NOVARTIS: OPERATING SEGMENTS
TABLE 59. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 60. PFIZER: COMPANY SNAPSHOT
TABLE 61. PFIZER: OPERATING SEGMENTS
TABLE 62. PFIZER: PRODUCT PORTFOLIO
TABLE 63. SANOFI: COMPANY SNAPSHOT
TABLE 64. SANOFI: OPERATING SEGMENTS
TABLE 65. SANOFI: PRODUCT PORTFOLIO
LIST OF FIGURE
LIST OF FIGURES
FIGURE 01. EUROPEAN ANTIBIOTICS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN THE EUROPEAN ANTIBIOTICS MARKET
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2017-2021*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2021* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2017-2021*
FIGURE 06. TOP PLAYER POSITIONING, 2019
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09. LOW THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. HIGH COMPETITIVE RIVALRY
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. EUROPEAN ANTIBIOTIC MARKET FOR BETA LACTAM AND BETA LACTAMASE INHIBITORS, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 14. PENICILLIN ANTIBIOTICS MARKET, 2019-2027 ($MILLION)
FIGURE 15. CEPHALOSPORIN ANTIBIOTICS MARKET, 2019-2027 ($MILLION)
FIGURE 16. CARBAPENEM ANTIBIOTICS MARKET, 2019-2027 ($MILLION)
FIGURE 17. MONOBACTAM ANTIBIOTICS MARKET, 2019-2027 ($MILLION)
FIGURE 18. EUROPEAN ANTIBIOTIC MARKET FOR QUINOLONES, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 19. EUROPEAN ANTIBIOTIC MARKET FOR MACROLIDE, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 20. EUROPEAN ANTIBIOTIC MARKET FOR OTHER, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 21. EUROPEAN NATURAL ANTIBIOTIC MARKET, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 22. EUROPEAN SEMISYNTHETIC ANTIBIOTIC MARKET, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 23. EUROPEAN SYNTHETIC INHIBITORS ANTIBIOTIC MARKET, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 24. EUROPEAN ANTIBIOTIC MARKET FOR BROAD SPECTRUM ANTIBIOTICS, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 25. EUROPEAN ANTIBIOTIC MARKET FOR NARROW SPECTRUM ANTIBIOTICS, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 26. EUROPEAN ORAL ANTIBIOTIC MARKET, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 27. EUROPEAN INTRAVENOUS ANTIBIOTIC MARKET, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 28. EUROPEAN ANTIBIOTIC MARKET FOR OTHERS, BY COUNTRY, 2019-2027 ($MILLION)
FIGURE 29. GERMANY ANTIBIOTIC MARKET, 2019-2027 ($MILLION)
FIGURE 30. FRANCE ANTIBIOTIC MARKET, 2019-2027 ($MILLION)
FIGURE 31. UK ANTIBIOTIC MARKET, 2019-2027 ($MILLION)
FIGURE 32. ITALY ANTIBIOTIC MARKET FOR ITALY, 2019-2027 ($MILLION)
FIGURE 33. SPAIN ANTIBIOTIC MARKET, 2019-2027 ($MILLION)
FIGURE 34. REST OF EUROPE ANTIBIOTIC MARKET, 2019-2027 ($MILLION)
FIGURE 35. ABBOTT: NET SALES, 2017-2019 ($MILLION)
FIGURE 36. ABBOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 37. ABBOTT: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 38. ABBVIE: NET SALES, 2017-2019 ($MILLION)
FIGURE 39. ABBVIE: REVENUE SHARE BY REGION, 2019(%)
FIGURE 40. BAYER: NET SALES, 2017-2019 ($MILLION)
FIGURE 41. BAYER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42. BAYER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43. ROCHE: NET SALES, 2018-2020 ($MILLION)
FIGURE 44. ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45. ROCHE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 46. GSK: NET SALES, 2017-2019 ($MILLION)
FIGURE 47. GSK: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 48. GSK: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 49. MERCK: NET SALES, 2017-2019 ($MILLION)
FIGURE 50. MERCK: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 51. MERCK: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 52. NOVARTIS: NET SALES, 2018-2020 ($MILLION)
FIGURE 53. NOVARTIS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 54. NOVARTIS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 55. PFIZER: NET SALES, 2017-2019 ($MILLION)
FIGURE 56. PFIZER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 57. PFIZER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 58. SANOFI: NET SALES, 2017-2019 ($MILLION)
FIGURE 59. SANOFI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 60. SANOFI: REVENUE SHARE BY REGION, 2019 (%)
